Does it Worth to Reinforce With Additional Anesthesia to Improve Postoperative Course After Orthognathic Surgery?
Launched by SERVEI CENTRAL D'ANESTESIOLOGIA · Jun 3, 2019
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Bimaxillary osteotomy is a surgical procedure in the field of orthognathic surgery (from Latin, "ortho" straight and "gnatho" jaw) for the correction of dentofacial deformities, both for functional and aesthetic reasons. The incidence of this deformity is estimated to be around the 5-10% of the population. Genetic, environmental and embryonic factors are postulated to be the origin of such deformity, though its origin is still unknown. The surgical technique is complex, with the performance of mandibular and upper jaw osteotomies that allow to advance, retrude, impact and rotate these bones...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients who undergo scheduled bimaxillary surgery
- Exclusion Criteria:
- • patients who are scheduled for bimaxillary surgery together with another complementary surgical procedure (such as mentoplasty, rhinoplasty, blepharoplasty)
- • age \<18 years
- • reinterventions
- • urgent surgeries
- • allergies to local anesthetics
- • allergies to anti-inflammatories agents
- • allergies to opioids
- • American Society of Anesthesiology Physical Status Examination System (ASA) \>3
About Servei Central D'anestesiologia
Servei Central d'Anestesiologia is a leading clinical trial sponsor specializing in the field of anesthesiology and perioperative medicine. Committed to advancing patient care through rigorous research, the organization conducts innovative clinical trials aimed at enhancing anesthesia techniques, improving patient outcomes, and optimizing pain management strategies. With a team of experienced professionals dedicated to ethical standards and scientific excellence, Servei Central d'Anestesiologia collaborates with healthcare institutions and researchers to contribute valuable insights to the medical community and ensure the safety and efficacy of anesthetic practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Patients applied
Trial Officials
Federico Hernández-Alfaro, MD, DDS, PhD
Study Director
Instituto Maxilofacial - Centro Médico Teknon
Miriam DeNadal, MD, PhD
Study Director
Hospital Valle de Hebrón
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials